Venus Concept (NASDAQ:VERO) Releases Quarterly Earnings Results, Misses Estimates By $1.22 EPS

Venus Concept (NASDAQ:VERO) released its quarterly earnings data on Monday. The company reported ($11.23) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($10.01) by ($1.22), RTT News reports. The firm had revenue of $15.77 million during the quarter, compared to the consensus estimate of $16.99 million. Venus Concept updated its Q1 2025 guidance to EPS.

Venus Concept Price Performance

NASDAQ:VERO opened at $2.62 on Wednesday. The firm’s 50-day simple moving average is $3.41 and its 200 day simple moving average is $4.18. Venus Concept has a 52 week low of $2.13 and a 52 week high of $17.49. The company has a debt-to-equity ratio of 2.83, a quick ratio of 1.18 and a current ratio of 1.86. The firm has a market cap of $1.73 million, a price-to-earnings ratio of -0.33 and a beta of 0.52.

About Venus Concept

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.